This message was sent to ##Email##
|
|
|
|
|
Critical Path Institute
C-Path's Transplant Therapeutics Consortium (TTC) announced this past Wednesday, June 17th, that a letter-of-Intent for the iBox Scoring System (Composite Biomarker Panel) as a reasonably likely surrogate endpoint from the Biomarker Qualification Program, was approved by the FDA. Read the full press release here.
Natera
The AST is partnering with Natera to offer a new patient town hall, "Navigating the COVID Crisis & the Reopening as a Transplant Patient." Scheduled to take place on Monday, June 22nd, 2020 at 12:00 pm EST, this event will feature special celebrity guest and kidney transplant recipient, George Lopez. The AST past-president, Dr. Emily Blumberg will be leading the discussion with Mr. Lopez. Learn more and register for the event here.
AST
To help us better understand the needs of our members, the AST has launched the Membership Value and Dues Survey. It's very important that we hear from YOU, our members, about whether we're meeting your needs, what we're doing well, and what we can do better. All participants in the survey will be eligible for a drawing to receive a $50 gift card.
Please check your email to access the survey.
|
Promoted by
|
|
|
|
 |
AST
The AST continues to update FAQ pages and other resources for both professionals and patients. This week, the COVID-19 FAQs for Organ Transplantation were updated, and can be seen here.
AST
As COVID-19 has had a profound impact on liver transplantation and patients with advanced chronic liver disease, the AASLD and the American Society of Transplantation (AST) have teamed up to provide an update on the management of COVID-19 in transplant candidates and recipients. Learn more and register here.
| . |
SPONSORED VIDEO |
Advertisement
|
 |
|
Promoted by
Veloxis Pharaceuticals
Watch kidney transplant patients talk about their diagnoses and the importance of communication with their doctors and transplant teams. For these patients, switching therapies made sense.
See the video
![]()
|
|
AST
The AST's Infectious Disease Community of Practice has received queries from
transplant and donation colleagues regarding the novel coronavirus (2019-nCoV). These
FAQs were developed with input of members from both the organ donation
and transplantation communities to relay information on the current state of knowledge.
Check our website frequently, as these resources are being updated regularly.
READ MORE
AST
Information regarding COVID-19 is changing rapidly. This document will be updated with the evolving issues related to medication access and drug shortages/supply chain issues within the United States of America during the pandemic.
 |
|
RELiZORB mimics the function of pancreatic lipase and delivers absorbable fats to your patients.
Indicated for use in pediatric patients (ages 5 years and above) and adult patients to hydrolyze fats in enteral formula.
Learn more at relizorb.com REL20-310
|
|
AST
In the interest of facilitating patient care and advancing science, and ensuring that accurate knowledge and experience is available to all during this current time of crisis, AJT has been expediting review of all papers dealing with COVID-19, as well as making them free to access for all.
READ MORE
Advertisement
EnvarsusXR
Did you know there’s a transplant support system to help patients and providers with best-in-class assistance and resources? This ongoing support system assists with benefit investigation, prior authorization assistance, coordination with specialty pharmacies, prescription fulfillment navigation, and CoverMyMeds® access. There’s also a $0 co-pay card to overcome financial barriers.
Find out more
|
AST
The Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act would extend Medicare coverage of immunosuppressive drugs for kidney transplant recipients, which is currently limited to just 36 months. Please take a moment to contact your Members of Congress about this important legislation. Contact Congress Today
AST
Originally recorded on April 15, 2020, Doctors Marina Serper and David Taber, with moderator Ms. Linda Ohler, discuss telemedicine, mHealth, and dashboards, both pre-COVID and in light of changes brought about by COVID-19 in "Advanced Technology in Transplant Care.” Access the webinar here.
|
|
AST
Transplant professionals have increasing demands on their time. Finding time in one’s day to attend conferences or to read journals is challenging. Transplant in 10 is intended to provide transplant professionals with short, easily accessible videos on key and updated topics in 10 minutes.
READ MORE
American Journal of Transplantation
The International Workshop on Clinical Transplant Tolerance is a biennial meeting that aims to provide an update on the progress of studies of immunosuppression minimization or withdrawal in solid organ transplantation. This report is a summary of presentations on the status of clinical trials designed to minimize or withdraw immunosuppressive drugs in kidney, liver and lung transplantation, without subsequent evidence of rejection.
READ MORE
|
|
Labs@HOME is a mobile phlebotomy in-home blood draw service to aid in specimen collection directly from a patient's home. Clinicians can order and customize a number of infectious disease and transplant-relatedtesting remotely
Learn more
|
|
|
|
|
Reach Your Prospects Every Week
Thousands of industry professionals subscribe to association news briefs, which allows your company to push messaging directly to their inboxes and take advantage of the association's brand affinity.
Connect with Highly Defined Buyers and Maximize Your Brand Exposure
|
|
|
|
|
American Journal of Transplantation
Minimization of immunosuppression and administration of antiretrovirals have been recommended for kidney transplant recipients (KTRs) with COVID‐19. However, outcomes remain poor. Given the likely benefit of cyclosporine due to its antiviral and immunomodulatory effect, we have been using it as a strategy in KTRs diagnosed with SARS‐CoV‐2.
READ MORE
American Journal of Transplantation
Viral‐induced heterologous immunity is considered a barrier to transplantation tolerance. Yet, hepatitis C (HCV) infected liver transplant (LT) patients occasionally achieve operational tolerance. We investigated the mechanisms through which HCV infection modulates donor‐specific T cell responses following LT and the influence of HCV eradication.
READ MORE
|
|
The Journal of Heart and Lung Transplantation
Acute Cellular Rejection (ACR) is a major complication in heart transplantation (HTx). Endomyocardial biopsy (EMB) is the reference method for ACR early detection, but a new non-invasive approach is needed. Tentative candidates could be circulating microRNAs. This study aimed to discover and validate microRNAs in serum for ACR detection after HTx.
READ MORE
Transplantation
Here, we present our initial experience with a prospective protocol of belatacept conversion in patients with caAMR and a high degree of chronicity at the time of diagnosis.
READ MORE
|
|
|
7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063
|
